Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04440917 · UNKNOWN
Trial details
- NCT number
- NCT04440917
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2022-06-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.